Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
0.0942
-0.0040 (-4.07%)
At close: May 12, 2025, 4:00 PM
0.0926
-0.0016 (-1.70%)
After-hours: May 12, 2025, 7:44 PM EDT
Lyra Therapeutics Market Cap
Lyra Therapeutics has a market cap or net worth of $6.24 million as of May 12, 2025. Its market cap has decreased by -98.04% in one year.
Market Cap
6.24M
Enterprise Value
7.86M
1-Year Change
-98.04%
Ranking
Category
Stock Price
$0.09
Market Cap Chart
Since May 1, 2020, Lyra Therapeutics's market cap has decreased from $230.14M to $6.24M, a decrease of -97.29%. That is a compound annual growth rate of -51.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 6.51M | -51.83% |
| Dec 31, 2024 | 13.51M | -95.09% |
| Dec 29, 2023 | 275.43M | 175.60% |
| Dec 30, 2022 | 99.94M | 76.26% |
| Dec 31, 2021 | 56.70M | -61.52% |
| Dec 31, 2020 | 147.37M | -35.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |